Monitoring of intracellular ribonucleoti
โ
Stefanos I. Grammatikos; Kai Tobien; Wolfgang Noรฉ; Rolf G. Werner
๐
Article
๐
1999
๐
John Wiley and Sons
๐
English
โ 242 KB
Efficient cell culture process development for the industrial production of recombinant therapeutics is characterized by constraints which pertain to issues such as costs, competitiveness and the meeting of project timelines. These constraints require tools which can help the developer learn as much